The Covid-19 vaccine made by Pfizer and BioNTech was granted a full approval by US regulators, a milestone expected to help bolster the immunisation drive.
Author: Agency Staff
Even a $1.5-trillion selloff may not provide an attractive entry point for equity investors as they grapple with cascading risks in China’s technology sector.
Recent decisions from South Africa and Australia that an artificial intelligence machine can be listed as inventor on a patent is putting greater pressure on the US and Europe to resolve debates over what it means to be an inventor.
Standard Bank will within years transform into a marketplace where clients can also access rivals’ products and a variety of services beyond just banking, it said on Friday.
Nvidia’s planned $40-billion acquisition of British chip designer ARM looks set to face a lengthy inquiry after a UK regulator found the deal would hit competition and could weaken rivals.
Eskom was able to avoid national rolling blackouts on Thursday evening, but only because there was a reduction in demand and because it made extensive use of emergency generation resources.
The European Commission said on Thursday it had reached a temporary agreement with South Africa to use a plant to bottle Johnson & Johnson Covid-19 vaccines, after criticism of the arrangement.
Tesla CEO Elon Musk said the electric car maker will probably launch a “Tesla Bot” humanoid robot prototype next year, designed for dangerous, repetitive, or boring work that people don’t like to do.
When Apple was looking to hire new management for its Siri and artificial intelligence groups, it went after a pair of high-profile targets: Google’s top brass overseeing search.
The five-and-a-half-hour outage on the JSE that prevented traders buying and selling stocks until well into the afternoon on Wednesday was not a good signal for a bourse that touts itself as Africa’s finest.